These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 26256206)
21. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone. Kalam MA Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165 [TBL] [Abstract][Full Text] [Related]
22. Bio-fabrication and statistical optimization of polysorbate 80 coated chitosan nanoparticles of tapentadol hydrochloride for central antinociceptive effect: in vitro-in vivo studies. Patil GB; Surana SJ Artif Cells Nanomed Biotechnol; 2017 May; 45(3):505-514. PubMed ID: 27017892 [TBL] [Abstract][Full Text] [Related]
23. Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles. Cetin M; Aktas Y; Vural I; Capan Y; Dogan LA; Duman M; Dalkara T Drug Deliv; 2007 Nov; 14(8):525-9. PubMed ID: 18027182 [TBL] [Abstract][Full Text] [Related]
24. Investigation on the properties of methoxy poly(ethylene glycol)/chitosan graft co-polymers. Deng L; Qi H; Yao C; Feng M; Dong A J Biomater Sci Polym Ed; 2007; 18(12):1575-89. PubMed ID: 17988521 [TBL] [Abstract][Full Text] [Related]
25. A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets. Li FQ; Yan C; Bi J; Lv WL; Ji RR; Chen X; Su JC; Hu JH Int J Nanomedicine; 2011; 6():897-904. PubMed ID: 21720502 [TBL] [Abstract][Full Text] [Related]
26. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers. Raja MA; Katas H; Jing Wen T PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222 [TBL] [Abstract][Full Text] [Related]
27. Development of chitosan-based nanoparticles through inter-polymeric complexation for oral drug delivery. Jana S; Maji N; Nayak AK; Sen KK; Basu SK Carbohydr Polym; 2013 Oct; 98(1):870-6. PubMed ID: 23987423 [TBL] [Abstract][Full Text] [Related]
28. Preparation and Characterization of an Oral Norethindrone Sustained Release/Controlled Release Nanoparticles Formulation Based on Chitosan. Altaani BM; Al-Nimry SS; Haddad RH; Abu-Dahab R AAPS PharmSciTech; 2019 Jan; 20(2):54. PubMed ID: 30617756 [TBL] [Abstract][Full Text] [Related]
29. Hematotoxicological analysis of surface-modified and -unmodified chitosan nanoparticles. Nadesh R; Narayanan D; P R S; Vadakumpully S; Mony U; Koyakkutty M; Nair SV; Menon D J Biomed Mater Res A; 2013 Oct; 101(10):2957-66. PubMed ID: 23613460 [TBL] [Abstract][Full Text] [Related]
30. Fabrication of letrozole formulation using chitosan nanoparticles through ionic gelation method. Gomathi T; Sudha PN; Florence JAK; Venkatesan J; Anil S Int J Biol Macromol; 2017 Nov; 104(Pt B):1820-1832. PubMed ID: 28185930 [TBL] [Abstract][Full Text] [Related]
31. Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box-Behnken experimental design. Abul Kalam M; Khan AA; Khan S; Almalik A; Alshamsan A Int J Biol Macromol; 2016 Jun; 87():329-40. PubMed ID: 26893052 [TBL] [Abstract][Full Text] [Related]
32. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery. Khalil SK; El-Feky GS; El-Banna ST; Khalil WA Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337 [TBL] [Abstract][Full Text] [Related]
33. Stability of chitosan nanoparticles for L-ascorbic acid during heat treatment in aqueous solution. Jang KI; Lee HG J Agric Food Chem; 2008 Mar; 56(6):1936-41. PubMed ID: 18284198 [TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells. Yang L; Gao S; Asghar S; Liu G; Song J; Wang X; Ping Q; Zhang C; Xiao Y Int J Biol Macromol; 2015 Jan; 72():1391-401. PubMed ID: 25450553 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of PEG-O-chitosan nanoparticles for delivery of poor water soluble drugs: ibuprofen. Hassani Najafabadi A; Abdouss M; Faghihi S Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():91-9. PubMed ID: 24907742 [TBL] [Abstract][Full Text] [Related]
36. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors. Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514 [TBL] [Abstract][Full Text] [Related]
37. Development of hydrophilic nanocarriers for the charged form of the local anesthetic articaine. Silva de Melo NF; Campos EV; Gonçalves CM; de Paula E; Pasquoto T; de Lima R; Rosa AH; Fraceto LF Colloids Surf B Biointerfaces; 2014 Sep; 121():66-73. PubMed ID: 24934456 [TBL] [Abstract][Full Text] [Related]
38. Development, optimization, and in vitro characterization of dasatinib-loaded PEG functionalized chitosan capped gold nanoparticles using Box-Behnken experimental design. Adena SKR; Upadhyay M; Vardhan H; Mishra B Drug Dev Ind Pharm; 2018 Mar; 44(3):493-501. PubMed ID: 29161920 [TBL] [Abstract][Full Text] [Related]
39. Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin. He Z; Santos JL; Tian H; Huang H; Hu Y; Liu L; Leong KW; Chen Y; Mao HQ Biomaterials; 2017 Jun; 130():28-41. PubMed ID: 28359018 [TBL] [Abstract][Full Text] [Related]
40. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells. Kumar SP; Birundha K; Kaveri K; Devi KT Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]